SCHEMBL24801949

SCHEMBL24801949

CC[C@]1(C)CN(Cc2ccccc2)CCN1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.51
CYP2D6 P10635 3/20 0.47
GAA P10253 1/20 0.46
TSHR P16473 3/20 0.45
CYP3A4 P08684 2/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HIF1A Q16665 1/20 0.44
MC4R P32245 1/20 0.44
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
ACHE P22303 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29156328 1.00 SIGMAR1 (0.51) SIGMAR1CYP2D6GAATSHRCYP3A4
SCHEMBL24801905 1.00 SIGMAR1 (0.51) SIGMAR1CYP2D6GAATSHRCYP3A4
SCHEMBL24801903 0.84 SIGMAR1 (0.47) SIGMAR1CYP2D6GAATSHRCYP3A4
SCHEMBL24801918 0.84 SIGMAR1 (0.47) SIGMAR1CYP2D6GAATSHRCYP3A4
SCHEMBL3134881 0.83 SIGMAR1 (0.56) SIGMAR1CYP2D6GAATSHRCYP3A4
SCHEMBL24802921 0.82 SIGMAR1 (0.45) SIGMAR1CYP2D6GAATSHRCYP3A4
SCHEMBL24802000 0.78 SIGMAR1 (0.47) SIGMAR1CYP2D6GAATSHRCYP3A4
SCHEMBL30761091 0.77 SIGMAR1 (0.46) SIGMAR1CYP2D6GAATSHRCYP3A4
SCHEMBL24803408 0.77 SIGMAR1 (0.49) SIGMAR1CYP2D6GAATSHRCYP3A4
SCHEMBL24802024 0.77 SIGMAR1 (0.49) SIGMAR1CYP2D6GAATSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117425649-A Pyrazole derivatives as KRAS mutein inhibitors 诺华股份有限公司 2024-01-19 CN disclosed
WO-2022269508-A1 PYRAZOLYL DERIVATIVES AS INHIBITORS OF THE KRAS MUTANT PROTEIN NOVARTIS AG (CH) 2022-12-29 WO disclosed